NPI-002 Intravitreal Implant for the Delay of Cataract Progression
Phase 1/2 – combined early trial
Conditions:
Cataract
Sponsor: Nacuity Pharmaceuticals, Inc.
trial.available_in:
БГ
Overview
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
Who can participate
Inclusion Criteria:
1. Indicated for vitrectomy
2. Natural Lens in place at time of vitrectomy
3. Some cataract present as assessed pre-operatively
Exclusion Criteria:
1. Previous intraocular surgery in study eye.
2. Clear zonular weakness or defects / coloboma.
3. Not on stable dose of medications for other conditions.
4. Need for oral corticosteroids during study participation.
5. Evidence or history of uveitis, or ocular ischemia.
6. Current smoker
7. Use of supplemental oxygen
8. Evidence or history of proliferative diabetic retinopathy.
9. Current lung disease (PU, COPD, Asthma) resulting in decreased oxygen saturation.
10. Sensitivity to thiol compounds.
11. Participation in another clinical trial.
БГ